Ensure: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study

L. Cantini; M. V. Dietz; R. A. Belderbos; R. Cornelissen; D. W. Dumoulin; M. Vink; K. Bezemer; A. W. Langerak; J. von der Thusen; E. A. F. Mahtab; L. P. W. M. Maat; R. Stadhouders; R. Hendriks; M. Willemsen; J. G. Aerts

doi:10.1016/j.annonc.2022.07.1721

Ensure: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study

L. Cantini, M. V. Dietz, R. A. Belderbos, R. Cornelissen, D. W. Dumoulin, M. Vink, K. Bezemer, A. W. Langerak, J. von der Thusen, E. A. F. Mahtab, L. P. W. M. Maat, R. Stadhouders, R. Hendriks, M. Willemsen, J. G. Aerts

Research output: Contribution to journal › Meeting Abstract › Popular

Original language	English
Pages (from-to)	S1292-S1292
Number of pages	1
Journal	Annals of Oncology
Volume	33
Issue number	7
DOIs	https://doi.org/10.1016/j.annonc.2022.07.1721
Publication status	Published - Sept 2022
Event	Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) - Duration: 9 Sept 2022 → 13 Sept 2022

Access to Document

10.1016/j.annonc.2022.07.1721

Cite this

Cantini, L., Dietz, M. V., Belderbos, R. A., Cornelissen, R., Dumoulin, D. W., Vink, M., Bezemer, K., Langerak, A. W., von der Thusen, J., Mahtab, E. A. F., Maat, L. P. W. M., Stadhouders, R., Hendriks, R., Willemsen, M., & Aerts, J. G. (2022). Ensure: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study. Annals of Oncology, 33(7), S1292-S1292. https://doi.org/10.1016/j.annonc.2022.07.1721

@article{eadf3dc6873241c0a2ec73ad9d6eb417,

title = "Ensure: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study",

author = "L. Cantini and Dietz, {M. V.} and Belderbos, {R. A.} and R. Cornelissen and Dumoulin, {D. W.} and M. Vink and K. Bezemer and Langerak, {A. W.} and {von der Thusen}, J. and Mahtab, {E. A. F.} and Maat, {L. P. W. M.} and R. Stadhouders and R. Hendriks and M. Willemsen and Aerts, {J. G.}",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.1721",

language = "English",

volume = "33",

pages = "S1292--S1292",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "7",

note = "Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) ; Conference date: 09-09-2022 Through 13-09-2022",

}

Cantini, L, Dietz, MV , Belderbos, RA , Cornelissen, R , Dumoulin, DW, Vink, M, Bezemer, K, Langerak, AW , von der Thusen, J , Mahtab, EAF, Maat, LPWM, Stadhouders, R, Hendriks, R, Willemsen, M & Aerts, JG 2022, 'Ensure: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study', Annals of Oncology, vol. 33, no. 7, pp. S1292-S1292. https://doi.org/10.1016/j.annonc.2022.07.1721

TY - JOUR

T1 - Ensure

T2 - Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)

AU - Cantini, L.

AU - Dietz, M. V.

AU - Belderbos, R. A.

AU - Cornelissen, R.

AU - Dumoulin, D. W.

AU - Vink, M.

AU - Bezemer, K.

AU - Langerak, A. W.

AU - von der Thusen, J.

AU - Mahtab, E. A. F.

AU - Maat, L. P. W. M.

AU - Stadhouders, R.

AU - Hendriks, R.

AU - Willemsen, M.

AU - Aerts, J. G.

PY - 2022/9

Y1 - 2022/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000866211602194&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/j.annonc.2022.07.1721

DO - 10.1016/j.annonc.2022.07.1721

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S1292-S1292

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

Y2 - 9 September 2022 through 13 September 2022

ER -

Ensure: Dendritic cell therapy (MesoPher) in combination with extended-pleurectomy/decortication after chemotherapy in subjects with resectable mesothelioma: A feasibility study

Access to Document

Other files and links

Cite this